Literature DB >> 17467674

The interchain disulfide linkage is not a prerequisite but enhances CD28 costimulatory function.

Eszter Lazar-Molnar1, Steven C Almo, Stanley G Nathenson.   

Abstract

Oligomeric state makes important contributions to the signaling mechanisms of costimulatory molecules. In this study we address the biological relevance of the disulfide-linked dimeric structure of CD28. Fluorescence Resonance Energy Transfer (FRET) demonstrates that removal of the interdomain disulfide bond (C123) does not interfere with the formation of CD28 oligomers on the cell surface. Although the C123S mutant shows 40% lower binding affinity to the ligand B7-1, it is able to costimulate anti-CD3-induced IL-2 production but at a lower level (150%) compared to the wild-type (270%). Interestingly, binding to B7-2 was not affected. Thus, the covalently linked dimeric structure of CD28 represents an important mechanistic determinant for the optimal costimulatory activity in the immunological synapse.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17467674      PMCID: PMC1976262          DOI: 10.1016/j.cellimm.2007.02.014

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  18 in total

Review 1.  The B7-CD28 superfamily.

Authors:  Arlene H Sharpe; Gordon J Freeman
Journal:  Nat Rev Immunol       Date:  2002-02       Impact factor: 53.106

2.  Clustering of peptide-loaded MHC class I molecules for endoplasmic reticulum export imaged by fluorescence resonance energy transfer.

Authors:  T Pentcheva; M Edidin
Journal:  J Immunol       Date:  2001-06-01       Impact factor: 5.422

3.  Molecular cloning of a CD28 cDNA by a high-efficiency COS cell expression system.

Authors:  A Aruffo; B Seed
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

Review 4.  The B7 family revisited.

Authors:  Rebecca J Greenwald; Gordon J Freeman; Arlene H Sharpe
Journal:  Annu Rev Immunol       Date:  2005       Impact factor: 28.527

5.  Crystal structure of a soluble CD28-Fab complex.

Authors:  Edward J Evans; Robert M Esnouf; Raquel Manso-Sancho; Robert J C Gilbert; John R James; Chao Yu; Janet A Fennelly; Cheryl Vowles; Thomas Hanke; Björn Walse; Thomas Hünig; Poul Sørensen; David I Stuart; Simon J Davis
Journal:  Nat Immunol       Date:  2005-02-06       Impact factor: 25.606

Review 6.  Fluorescence resonance energy transfer: techniques for measuring molecular conformation and molecular proximity.

Authors:  Michael Edidin
Journal:  Curr Protoc Immunol       Date:  2003-02

7.  Cutting edge: distinct motifs within CD28 regulate T cell proliferation and induction of Bcl-XL.

Authors:  J S Burr; N D Savage; G E Messah; S L Kimzey; A S Shaw; R H Arch; J M Green
Journal:  J Immunol       Date:  2001-05-01       Impact factor: 5.422

8.  The murine homologue of the T lymphocyte antigen CD28. Molecular cloning and cell surface expression.

Authors:  J A Gross; T St John; J P Allison
Journal:  J Immunol       Date:  1990-04-15       Impact factor: 5.422

9.  Different cell surface oligomeric states of B7-1 and B7-2: implications for signaling.

Authors:  Sumeena Bhatia; Michael Edidin; Steven C Almo; Stanley G Nathenson
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-12       Impact factor: 11.205

10.  Transcriptional mechanisms underlying lymphocyte tolerance.

Authors:  Fernando Macián; Francisco García-Cózar; Sin-Hyeog Im; Heidi F Horton; Michael C Byrne; Anjana Rao
Journal:  Cell       Date:  2002-06-14       Impact factor: 41.582

View more
  9 in total

Review 1.  PD-1 signaling in primary T cells.

Authors:  James L Riley
Journal:  Immunol Rev       Date:  2009-05       Impact factor: 12.988

2.  Analysis of receptor oligomerization by FRAP microscopy.

Authors:  Sandra Dorsch; Karl-Norbert Klotz; Stefan Engelhardt; Martin J Lohse; Moritz Bünemann
Journal:  Nat Methods       Date:  2009-02-22       Impact factor: 28.547

3.  A CD200R-CD28 fusion protein appropriates an inhibitory signal to enhance T-cell function and therapy of murine leukemia.

Authors:  Shannon K Oda; Andrew W Daman; Nicolas M Garcia; Felecia Wagener; Thomas M Schmitt; Xiaoxia Tan; Aude G Chapuis; Philip D Greenberg
Journal:  Blood       Date:  2017-10-17       Impact factor: 22.113

Review 4.  Co-stimulation Blockade Plus T-Cell Depletion in Transplant Patients: Towards a Steroid- and Calcineurin Inhibitor-Free Future?

Authors:  Florence Herr; Melanie Brunel; Nathalie Roders; Antoine Durrbach
Journal:  Drugs       Date:  2016-11       Impact factor: 9.546

5.  The Contribution of the Minimal Promoter Element to the Activity of Synthetic Promoters Mediating CAR Expression in the Tumor Microenvironment.

Authors:  Yariv Greenshpan; Omri Sharabi; Ksenia M Yegodayev; Ofra Novoplansky; Moshe Elkabets; Roi Gazit; Angel Porgador
Journal:  Int J Mol Sci       Date:  2022-07-04       Impact factor: 6.208

6.  Analysis of transient membrane protein interactions by single-molecule diffusional mobility shift assay.

Authors:  Min Gyu Jeong; Kai Zhou; Soyeon Park; HyeongJeon An; Yonghoon Kwon; Yeonho Chang; Do-Hyeon Kim; Sung Ho Ryu
Journal:  Exp Mol Med       Date:  2021-02-19       Impact factor: 8.718

7.  The Effects of Chimeric Antigen Receptor (CAR) Hinge Domain Post-Translational Modifications on CAR-T Cell Activity.

Authors:  Sachiko Hirobe; Keisuke Imaeda; Masashi Tachibana; Naoki Okada
Journal:  Int J Mol Sci       Date:  2022-04-06       Impact factor: 5.923

8.  The CD28 Transmembrane Domain Contains an Essential Dimerization Motif.

Authors:  Scott A Leddon; Margaret M Fettis; Kristin Abramo; Ryan Kelly; David Oleksyn; Jim Miller
Journal:  Front Immunol       Date:  2020-07-16       Impact factor: 7.561

9.  Hinge and Transmembrane Domains of Chimeric Antigen Receptor Regulate Receptor Expression and Signaling Threshold.

Authors:  Kento Fujiwara; Ayaka Tsunei; Hotaka Kusabuka; Erika Ogaki; Masashi Tachibana; Naoki Okada
Journal:  Cells       Date:  2020-05-09       Impact factor: 6.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.